Tonix Pharmaceuticals Holding (TNXP) Finished Goods (2023 - 2025)

Tonix Pharmaceuticals Holding's Finished Goods history runs 3 years deep, the most recent figure standing at $2.1 million for Q4 2025.

• On a quarterly basis, Finished Goods fell 58.29% year-over-year to $2.1 million in Q4 2025; TTM through Dec 2025 was $2.1 million, a 58.29% decrease from a year earlier, with the FY2025 full-year figure at $2.1 million, down 58.29% from the prior year.
• Finished Goods advanced to $2.1 million in Q4 2025 per TNXP's latest filing, from $1.8 million in the prior quarter.
• Across five years, Finished Goods topped out at $7.5 million in Q4 2023 and bottomed at $1.8 million in Q3 2025.
• The 3-year median for Finished Goods is $2.6 million (2024), against an average of $3.8 million.
• Across the five-year window, Finished Goods plunged 31.58% in 2024 and slumped 58.29% in 2025, its largest moves.
• Year by year, Finished Goods stood at $7.5 million in 2023, then tumbled by 31.58% to $5.1 million in 2024, then slumped by 58.29% to $2.1 million in 2025.
• Per Business Quant, the three latest TNXP Finished Goods figures stand at $2.1 million (Q4 2025), $1.8 million (Q3 2025), and $2.4 million (Q2 2025).